Bruce . I know nothing of a pre-negotiated price. I know this. I know that Immune sold 50 percent stake including Bert to Alexion for a billion plus dollars. I know Cytovia was determined by third party bank to have a 10 dollar valuation in 2022. I know Cytovia also concluded that it would have a new 15 dollar valuation in second anniversary of 2023 and a 20 dollar valuation in 2nd anniversary of 2024. I believe that the first additional 5 dollar value is what’s coming from Naya hence the 5 dollar value. This is what explains the 2023 merger recap. Are they behind on these transactions. Definitely yes. They’re just dragging their feet as usual. The next additional 5 dollar recap will be coming from the new 2024 merger Satellos Bioscience. These two mergers will put Cytovia’s next valuation at the new 20 dollar mark in 2024. Then after all is complete, at the very tail end of 2024, most likely 3rd quarter, we should expect to see another deal which is ESHA which will be the deal that takes them public. This SPAC transaction should complete in early 2025 and soon after Astra will complete acquisition and roll it all up. Hope this helps. This is just my own assumption that’s purely based off speculation on my part. Don’t go expecting a listing. I sure don’t. I could be wrong. Not likely, but I do welcome change if it happens. Liquidity is a good thing. If my conclusions however are right, I can then only be left to assume there will never be a real big lapse of time at the end where all is separated. I believe Astra will absorb everything in one large transaction. Pretty crazy. But that’s my belief. If I’m wrong, so be it. It’s been fun forming my conclusion. Hula Hula Cuckoo Penny
AI
